Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Monday, November 17, 2014 A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors. read more

View post:
Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs